{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,6]],"date-time":"2026-10-06T18:52:54Z","timestamp":1791312774467,"version":"4.3.1"},"reference-count":43,"publisher":"Oxford University Press (OUP)","issue":"11","license":[{"start":{"date-parts":[[2014,12,1]],"date-time":"2014-12-01T00:00:00Z","timestamp":1417392000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/academic.oup.com\/pages\/standard-publication-reuse-rights"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2014,12,1]]},"abstract":"<jats:title>Abstract<\/jats:title>\n               <jats:p>Myeloid-derived suppressor cells (MDSCs) are major immunosuppressive cells that lead to T cell defects in cancer. IL-18 is important in inflammatory and immune responses. IL-18 has been reported to have a dual effect on tumor progression, as it not only stimulates host immune responses, but also exerts procancer effects by inducing immune escape and angiogenesis. In the present study, we investigated the effect of IL-18 on MDSCs and found that IL-18 treatment significantly increased the percentage and the absolute number of monocytic MDSCs (M-MDSCs) via differentiation of CD11b\u2212 bone marrow progenitor cells. IL-18\u2013induced MDSCs showed enhanced suppression of T cell proliferation and IFN-\u03b3 production along with a dramatic increase of M-MDSC suppressive function, including NO production and arginase 1 expression. Although IL-18 decreased the number of granulocytic MDSCs (G-MDSCs) in a concentration-dependent manner, we found that the absolute number of G-MDSCs and their reactive oxygen species production remained unchanged. Additionally, we demonstrated that IL-18\u2013induced M-MDSCs have a more potent suppressive effect on T cell responses with lower IFN-\u03b3 production than do G-MDSCs, suggesting that the increased suppressive effect observed in our study resulted from M-MDSCs. Furthermore, in vivo administration of IL-18 significantly increased the accumulation of M-MDSCs in the tumor microenvironment. Taken together, our findings indicate that IL-18 specifically enhances the differentiation and function of M-MDSCs, leading to immunosuppression.<\/jats:p>","DOI":"10.4049\/jimmunol.1401282","type":"journal-article","created":{"date-parts":[[2014,11,1]],"date-time":"2014-11-01T08:54:25Z","timestamp":1414832065000},"page":"5453-5460","source":"Crossref","is-referenced-by-count":68,"title":["IL-18 Enhances Immunosuppressive Responses by Promoting Differentiation into Monocytic Myeloid-Derived Suppressor Cells"],"prefix":"10.1093","volume":"193","author":[{"given":"Hui Xuan","family":"Lim","sequence":"first","affiliation":[{"name":"Division of Life Sciences, College of Life Sciences and Biotechnology, Korea University , Seoul 136-701 ,","place":["Republic of Korea"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hye-Jin","family":"Hong","sequence":"additional","affiliation":[{"name":"Division of Life Sciences, College of Life Sciences and Biotechnology, Korea University , Seoul 136-701 ,","place":["Republic of Korea"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Daeho","family":"Cho","sequence":"additional","affiliation":[{"name":"Department of Life Science, Sookmyung Women\u2019s University , Seoul 140-742 ,","place":["Republic of Korea"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tae Sung","family":"Kim","sequence":"additional","affiliation":[{"name":"Division of Life Sciences, College of Life Sciences and Biotechnology, Korea University , Seoul 136-701 ,","place":["Republic of Korea"]}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"286","published-online":{"date-parts":[[2014,12,1]]},"reference":[{"key":"2025030707482101100_r1","doi-asserted-by":"crossref","first-page":"162","DOI":"10.1038\/nri2506","article-title":"Myeloid-derived suppressor cells as regulators of the immune system","volume":"9","author":"Gabrilovich","year":"2009","journal-title":"Nat. Rev. Immunol."},{"key":"2025030707482101100_r2","doi-asserted-by":"crossref","first-page":"739","DOI":"10.1038\/nrc3581","article-title":"History of myeloid-derived suppressor cells","volume":"13","author":"Talmadge","year":"2013","journal-title":"Nat. Rev. Cancer"},{"key":"2025030707482101100_r3","doi-asserted-by":"crossref","first-page":"5791","DOI":"10.4049\/jimmunol.181.8.5791","article-title":"Subsets of myeloid-derived suppressor cells in tumor-bearing mice","volume":"181","author":"Youn","year":"2008","journal-title":"J. Immunol."},{"key":"2025030707482101100_r4","doi-asserted-by":"crossref","first-page":"1220","DOI":"10.1002\/eji.201242841","article-title":"\u03b2-Glucan enhances antitumor immune responses by regulating differentiation and function of monocytic myeloid-derived suppressor cells","volume":"43","author":"Tian","year":"2013","journal-title":"Eur. J. Immunol."},{"key":"2025030707482101100_r5","first-page":"15","article-title":"Interleukin-18: biological properties and clinical implications","volume":"11","author":"Lebel-Binay","year":"2000","journal-title":"Eur. Cytokine Netw."},{"key":"2025030707482101100_r6","doi-asserted-by":"crossref","first-page":"3231","DOI":"10.1002\/(SICI)1521-4141(199810)28:10<3231::AID-IMMU3231>3.0.CO;2-Q","article-title":"Production of functional IL-18 by different subtypes of murine and human dendritic cells (DC): DC-derived IL-18 enhances IL-12-dependent Th1 development","volume":"28","author":"Stoll","year":"1998","journal-title":"Eur. J. Immunol."},{"key":"2025030707482101100_r7","doi-asserted-by":"crossref","first-page":"S370","DOI":"10.1086\/374751","article-title":"Interleukin-18 and host defense against infection","volume":"187","author":"Dinarello","year":"2003","journal-title":"J. Infect. Dis."},{"key":"2025030707482101100_r8","doi-asserted-by":"crossref","first-page":"323","DOI":"10.4049\/jimmunol.169.1.323","article-title":"Contribution of IL-18 to Th1 response and host defense against infection by Mycobacterium tuberculosis: a comparative study with IL-12p40","volume":"169","author":"Kinjo","year":"2002","journal-title":"J. Immunol."},{"key":"2025030707482101100_r9","doi-asserted-by":"crossref","first-page":"368","DOI":"10.1002\/eji.200636766","article-title":"IL-18, but not IL-12, is required for optimal cytokine production by influenza virus-specific CD8+ T cells","volume":"37","author":"Denton","year":"2007","journal-title":"Eur. J. Immunol."},{"key":"2025030707482101100_r10","first-page":"329","article-title":"The dual effects of interleukin-18 in tumor progression","volume":"4","author":"Park","year":"2007","journal-title":"Cell. Mol. Immunol."},{"key":"2025030707482101100_r11","doi-asserted-by":"crossref","first-page":"1468","DOI":"10.1038\/sj.onc.1209926","article-title":"Interleukin-18 is a critical factor for vascular endothelial growth factor-enhanced migration in human gastric cancer cell lines","volume":"26","author":"Kim","year":"2007","journal-title":"Oncogene"},{"key":"2025030707482101100_r12","doi-asserted-by":"crossref","first-page":"125","DOI":"10.1016\/j.imlet.2006.08.004","article-title":"IL-18 enhances the migration ability of murine melanoma cells through the generation of ROI and the MAPK pathway","volume":"107","author":"Jung","year":"2006","journal-title":"Immunol. Lett."},{"key":"2025030707482101100_r13","first-page":"2703","article-title":"Endogenous interleukin-18 modulates immune escape of murine melanoma cells by regulating the expression of Fas ligand and reactive oxygen intermediates","volume":"60","author":"Cho","year":"2000","journal-title":"Cancer Res."},{"key":"2025030707482101100_r14","doi-asserted-by":"crossref","first-page":"221","DOI":"10.1111\/j.1365-2567.2011.03429.x","article-title":"The role of interleukin-12 on modulating myeloid-derived suppressor cells, increasing overall survival and reducing metastasis","volume":"133","author":"Steding","year":"2011","journal-title":"Immunology"},{"key":"2025030707482101100_r15","doi-asserted-by":"crossref","first-page":"273","DOI":"10.1007\/s00430-010-0151-4","article-title":"Subsets, expansion and activation of myeloid-derived suppressor cells","volume":"199","author":"Ribechini","year":"2010","journal-title":"Med. Microbiol. Immunol. (Berl.)"},{"key":"2025030707482101100_r16","doi-asserted-by":"crossref","first-page":"3347","DOI":"10.1002\/eji.201041037","article-title":"IL-1\u03b2 regulates a novel myeloid-derived suppressor cell subset that impairs NK cell development and function","volume":"40","author":"Elkabets","year":"2010","journal-title":"Eur. J. Immunol."},{"key":"2025030707482101100_r17","doi-asserted-by":"crossref","first-page":"2101","DOI":"10.1182\/blood.V98.7.2101","article-title":"Interleukin-18 stimulates hematopoietic cytokine and growth factor formation and augments circulating granulocytes in mice","volume":"98","author":"Ogura","year":"2001","journal-title":"Blood"},{"key":"2025030707482101100_r18","doi-asserted-by":"crossref","first-page":"4036","DOI":"10.1172\/JCI36264","article-title":"Invariant NKT cells reduce the immunosuppressive activity of influenza A virus-induced myeloid-derived suppressor cells in mice and humans","volume":"118","author":"De Santo","year":"2008","journal-title":"J. Clin. Invest."},{"key":"2025030707482101100_r19","doi-asserted-by":"crossref","first-page":"718","DOI":"10.1016\/j.imbio.2012.08.271","article-title":"Myeloid derived suppressor cells (MDSCs) can induce the generation of Th17 response from naive CD4+ T cells","volume":"218","author":"Chatterjee","year":"2013","journal-title":"Immunobiology"},{"key":"2025030707482101100_r20","doi-asserted-by":"crossref","first-page":"4295","DOI":"10.4049\/jimmunol.1200086","article-title":"Mouse CD11b+Gr-1+ myeloid cells can promote Th17 cell differentiation and experimental autoimmune encephalomyelitis","volume":"189","author":"Yi","year":"2012","journal-title":"J. Immunol."},{"key":"2025030707482101100_r21","doi-asserted-by":"crossref","first-page":"2439","DOI":"10.1084\/jem.20100587","article-title":"HIF-1\u03b1 regulates function and differentiation of myeloid-derived suppressor cells in the tumor microenvironment","volume":"207","author":"Corzo","year":"2010","journal-title":"J. Exp. Med."},{"key":"2025030707482101100_r22","doi-asserted-by":"crossref","first-page":"179","DOI":"10.1016\/j.cyto.2013.04.029","article-title":"Principal role of IL-12p40 in the decreased Th1 and Th17 responses driven by dendritic cells of mice lacking IL-12 and IL-18","volume":"63","author":"Lim","year":"2013","journal-title":"Cytokine"},{"key":"2025030707482101100_r23","doi-asserted-by":"crossref","first-page":"39","DOI":"10.1007\/s10549-009-0622-8","article-title":"GM-CSF is one of the main breast tumor-derived soluble factors involved in the differentiation of CD11b\u2212Gr1\u2212 bone marrow progenitor cells into myeloid-derived suppressor cells","volume":"123","author":"Morales","year":"2010","journal-title":"Breast Cancer Res. Treat."},{"key":"2025030707482101100_r24","doi-asserted-by":"crossref","first-page":"2943","DOI":"10.1002\/eji.201343472","article-title":"Polyunsaturated fatty acids promote the expansion of myeloid-derived suppressor cells by activating the JAK\/STAT3 pathway","volume":"43","author":"Yan","year":"2013","journal-title":"Eur. J. Immunol."},{"key":"2025030707482101100_r25","doi-asserted-by":"crossref","first-page":"5393","DOI":"10.1158\/0008-5472.CAN-11-0993","article-title":"IL-18 induces PD-1-dependent immunosuppression in cancer","volume":"71","author":"Terme","year":"2011","journal-title":"Cancer Res."},{"key":"2025030707482101100_r26","first-page":"552","article-title":"Hematopoietic growth factors in the reduction of chemotherapeutic toxicity","volume":"25","author":"Johnston","year":"1998","journal-title":"Semin. Oncol."},{"key":"2025030707482101100_r27","doi-asserted-by":"crossref","first-page":"464","DOI":"10.4049\/jimmunol.172.1.464","article-title":"Hyperactivation of STAT3 is involved in abnormal differentiation of dendritic cells in cancer","volume":"172","author":"Nefedova","year":"2004","journal-title":"J. Immunol."},{"key":"2025030707482101100_r28","doi-asserted-by":"crossref","first-page":"550","DOI":"10.4161\/onci.19334","article-title":"Identification of a G-CSF-granulocytic MDSC axis that promotes tumor progression","volume":"1","author":"Abrams","year":"2012","journal-title":"OncoImmunology"},{"key":"2025030707482101100_r29","doi-asserted-by":"crossref","first-page":"e27690","DOI":"10.1371\/journal.pone.0027690","article-title":"Tumor-derived G-CSF facilitates neoplastic growth through a granulocytic myeloid-derived suppressor cell-dependent mechanism","volume":"6","author":"Waight","year":"2011","journal-title":"PLoS ONE"},{"key":"2025030707482101100_r30","doi-asserted-by":"crossref","first-page":"2561","DOI":"10.1158\/0008-5472.CAN-07-6229","article-title":"Tumor escape mechanism governed by myeloid-derived suppressor cells","volume":"68","author":"Nagaraj","year":"2008","journal-title":"Cancer Res."},{"key":"2025030707482101100_r31","doi-asserted-by":"crossref","first-page":"581","DOI":"10.3109\/08820139.2012.680635","article-title":"Immune suppression: the hallmark of myeloid derived suppressor cells","volume":"41","author":"Haile","year":"2012","journal-title":"Immunol. Invest."},{"key":"2025030707482101100_r32","doi-asserted-by":"crossref","first-page":"2969","DOI":"10.1002\/eji.201040895","article-title":"The biology of myeloid-derived suppressor cells: the blessing and the curse of morphological and functional heterogeneity","volume":"40","author":"Youn","year":"2010","journal-title":"Eur. J. Immunol."},{"key":"2025030707482101100_r33","doi-asserted-by":"crossref","first-page":"22","DOI":"10.1002\/eji.200939903","article-title":"Hierarchy of immunosuppressive strength among myeloid-derived suppressor cell subsets is determined by GM-CSF","volume":"40","author":"Dolcetti","year":"2010","journal-title":"Eur. J. Immunol."},{"key":"2025030707482101100_r34","doi-asserted-by":"crossref","first-page":"e24241","DOI":"10.1371\/journal.pone.0024241","article-title":"IL-18 inhibits growth of murine orthotopic prostate carcinomas via both adaptive and innate immune mechanisms","volume":"6","author":"Tse","year":"2011","journal-title":"PLoS ONE"},{"key":"2025030707482101100_r35","doi-asserted-by":"crossref","first-page":"2195","DOI":"10.1096\/fasebj.13.15.2195","article-title":"Interleukin-18 acts as an angiogenesis and tumor suppressor","volume":"13","author":"Cao","year":"1999","journal-title":"FASEB J."},{"key":"2025030707482101100_r36","doi-asserted-by":"crossref","first-page":"1747","DOI":"10.3748\/wjg.v13.i11.1747","article-title":"Expression and significance of intratumoral interleukin-12 and interleukin-18 in human gastric carcinoma","volume":"13","author":"Ye","year":"2007","journal-title":"World J. Gastroenterol."},{"key":"2025030707482101100_r37","doi-asserted-by":"crossref","first-page":"126","DOI":"10.1177\/172460080101600207","article-title":"Serum levels of interleukin-18 and sICAM-1 in patients affected by breast cancer: preliminary considerations","volume":"16","author":"Merendino","year":"2001","journal-title":"Int. J. Biol. Markers"},{"key":"2025030707482101100_r38","doi-asserted-by":"crossref","first-page":"417","DOI":"10.1007\/s10555-006-9013-3","article-title":"Clinical and experimental approaches to the pathophysiology of interleukin-18 in cancer progression","volume":"25","author":"Vidal-Vanaclocha","year":"2006","journal-title":"Cancer Metastasis Rev."},{"key":"2025030707482101100_r39","doi-asserted-by":"crossref","first-page":"11","DOI":"10.1038\/nrc1252","article-title":"Cytokines in cancer pathogenesis and cancer therapy","volume":"4","author":"Dranoff","year":"2004","journal-title":"Nat. Rev. Cancer"},{"key":"2025030707482101100_r40","doi-asserted-by":"crossref","first-page":"231","DOI":"10.4049\/jimmunol.157.1.231","article-title":"Systemic administration of cellular IL-10 induces an effective, specific, and long-lived immune response against established tumors in mice","volume":"157","author":"Berman","year":"1996","journal-title":"J. Immunol."},{"key":"2025030707482101100_r41","doi-asserted-by":"crossref","first-page":"121","DOI":"10.1006\/meth.1999.0837","article-title":"Interleukin-18","volume":"19","author":"Dinarello","year":"1999","journal-title":"Methods"},{"key":"2025030707482101100_r42","doi-asserted-by":"crossref","first-page":"1441","DOI":"10.1172\/JCI1555","article-title":"Interleukin-12 and interleukin-18 synergistically induce murine tumor regression which involves inhibition of angiogenesis","volume":"101","author":"Coughlin","year":"1998","journal-title":"J. Clin. Invest."},{"key":"2025030707482101100_r43","first-page":"884","article-title":"Interleukin-18 (IL-18) synergizes with IL-2 to enhance cytotoxicity, interferon-gamma production, and expansion of natural killer cells","volume":"61","author":"Son","year":"2001","journal-title":"Cancer Res."}],"container-title":["The Journal of Immunology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/academic.oup.com\/jimmunol\/article-pdf\/193\/11\/5453\/62229279\/1401282.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"syndication"},{"URL":"https:\/\/academic.oup.com\/jimmunol\/article-pdf\/193\/11\/5453\/62229279\/1401282.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,3,7]],"date-time":"2025-03-07T08:19:58Z","timestamp":1741335598000},"score":1,"resource":{"primary":{"URL":"https:\/\/academic.oup.com\/jimmunol\/article\/193\/11\/5453\/7967167"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2014,12,1]]},"references-count":43,"journal-issue":{"issue":"11","published-print":{"date-parts":[[2014,12,1]]}},"URL":"https:\/\/doi.org\/10.4049\/jimmunol.1401282","relation":{},"ISSN":["0022-1767","1550-6606"],"issn-type":[{"value":"0022-1767","type":"print"},{"value":"1550-6606","type":"electronic"}],"subject":[],"published-other":{"date-parts":[[2014,12]]},"published":{"date-parts":[[2014,12,1]]}}}